This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Sean A. Wright
Harvard Medical School

Douglas B. Sawyer, MD, PhD; David B. Sacks, MB, ChB
Susanna Chyu

Samuel Z. Goldhaber, MD
Brigham and Women's Hospital Boston, Mass

JAMA. 1997;278(24):2144.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The cardiac isoform of troponin I (TnI) has been touted as 100% specific for myocardial injury.^1-3 While serving on the consult service of a large teaching hospital, we occasionally have evaluated patients with chest pain and elevations of TnI levels in whom we were unable to find any evidence of myocardial injury. We reviewed consecutive patients evaluated at our hospital between January and June 1996 who had elevated serum TnI levels to determine the specificity of this assay for myocardial injury in clinical practice.

Troponin I levels were obtained as part of routine clinical practice when myocardial injury was suspected, and 343 patients had 1 or more TnI values of 1.0 ng/mL or greater. Cardiac TnI was measured on the Stratus II analyzer (Baxter Dade, Miami, Fla) with a commercial immunoassay procedure that uses 2 monoclonal antibodies directed against different epitopes on TnI.⁴

Of the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?